Showing results (61-70 of 121) with videos related to

Sort By:
Pageof 13
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 23, 2025
Clinical outcomes of proton beam therapy for inoperable stage I-IIA non-small cell lung cancer: Japanese nationwide registry studyMasaki Nakamura, Kazushi Maruo, Masao Murakami, et al.
Future Oncology (London, England)|September 25, 2025
RELAY: safety and efficacy of ramucirumab plus erlotinib in elderly Japanese patients with metastatic EGFR-mutated NSCLCKazumi Nishino, Takashi Seto, Makoto Nishio, et al.
Heliyon|October 12, 2023
Drug-induced interstitial lung disease after chemoimmunotherapy for extensive-stage small cell lung cancerKiyoko Fukuda, Naoko Katsurada, Yoshitaka Kawa, et al.
Lung Cancer (Amsterdam, Netherlands)|April 16, 2024
Long-term follow-up and exploratory analysis of lenvatinib in patients with metastatic or recurrent thymic carcinoma: Results from the multicenter, phase 2 REMORA trialSeiji Niho, Jun Sato, Miyako Satouchi, et al.
Lung Cancer (Amsterdam, Netherlands)|January 20, 2020
Randomized phase II study of chemoradiotherapy with cisplatin + S-1 versus cisplatin + pemetrexed for locally advanced non-squamous non-small cell lung cancer: SPECTRA studySeiji Niho, Tatsuya Yoshida, Tetsuo Akimoto, et al.
Japanese Journal of Clinical Oncology|February 24, 2018
Phase 3 study of ceritinib vs chemotherapy in ALK-rearranged NSCLC patients previously treated with chemotherapy and crizotinib (ASCEND-5): Japanese subsetKatsuyuki Kiura, Fumio Imamura, Hiroshi Kagamu, et al.
The Journal of Medical Investigation : JMI|September 29, 2017
Phase I/II study of alectinib in lung cancer with RET fusion gene: study protocolShinji Takeuchi, Toshinori Murayama, Kenichi Yoshimura, et al.
Cancer|April 6, 2013
Phase 2 study of S-1 and carboplatin plus bevacizumab followed by maintenance S-1 and bevacizumab for chemotherapy-naive patients with advanced nonsquamous non-small cell lung cancerYoshiko Urata, Isamu Okamoto, Masayuki Takeda, et al.
Lung Cancer (Amsterdam, Netherlands)|June 22, 2015
A randomized phase II study of bevacizumab in combination with docetaxel or S-1 in patients with non-squamous non-small-cell lung cancer previously treated with platinum based chemotherapy (HANSHIN Oncology Group 0110)Kazumi Nishino, Fumio Imamura, Toru Kumagai, et al.
Lung Cancer (Amsterdam, Netherlands)|March 16, 2021
Final survival results for the LURET phase II study of vandetanib in previously treated patients with RET-rearranged advanced non-small cell lung cancerKiyotaka Yoh, Takashi Seto, Miyako Satouchi, et al.
Pageof 13